 | Vanda Pharmaceuticals Inc. | |||
| NGM : VNDA || Location: United States | ||||
$4.56-0.07 (-1.51%) |
1.18 M | 4.55 - 4.67 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.485 M |
| March 15, 2024 | 3.001 M |
| Feb. 29, 2024 | 3.241 M |
| Feb. 15, 2024 | 2.960 M |
| Jan. 31, 2024 | 2.294 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.09 | -0.04 | 56.43% |
| 06/30/2023 | -0.13 | 0.03 | 122.62% |
| 12/31/2022 | 0.08 | 0.12 | 50.00% |
| 09/30/2022 | 0.09 | 0.06 | -33.30% |
| 06/30/2022 | 0.11 | 0.05 | -54.50% |
VNDA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 57.538M | Shares Float | 52.046M |
| Short Float | 2.485M | Market Cap | 266.40M |
| Institution ownership | 90.97% | Insider ownership | 5.207% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.04 | Forward EPS | -0.33 |